Management of paediatric IBD after the peak of COVID-19 pandemic in Italy: A position paper on behalf of the SIGENP IBD working group.
Dig Liver Dis
; 53(2): 183-189, 2021 02.
Article
in English
| MEDLINE | ID: covidwho-885252
ABSTRACT
Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2, spreading in Italy during the first months of 2020, abruptly changed the way of practicing medicine in this country. As a consequence of the lockdown, the diagnostic and therapeutic management of paediatric chronic conditions, such as inflammatory bowel disease (IBD) has been affected. During the peak of COVID-19 pandemic, elective visits, endoscopies and infusions have been postponed, with potential clinical and psychological impact on disease course and a high likelihood of increasing waiting lists. While slowly moving back towards normality, clinicians need to recognize the best ways to care for patients with IBD, carefully avoiding risk factors for new potential epidemic outbreaks. In this uncertain scenario until the development and spread of COVID-19 vaccine, it is necessary to continue to operate with caution. Hereby we provide useful indications for a safer and gradual restarting of routine clinical activities after COVID-19 peak in Italy.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pediatrics
/
Inflammatory Bowel Diseases
/
Communicable Disease Control
/
Gastroenterology
/
COVID-19
Type of study:
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Child
/
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
Dig Liver Dis
Journal subject:
Gastroenterology
Year:
2021
Document Type:
Article
Affiliation country:
J.dld.2020.10.024
Similar
MEDLINE
...
LILACS
LIS